We are looking for a Software and Database Developer to our office in Malmö, Sweden. You will be working with our engineering team to provide actionable and data-informed insights that impact the quality of life for many people. We value insight driven innovation, collaboration, and feedback. This is a place where individual passion to improve lives directs our collective curiosity, which fuels the ideas, and projects we use our talents to deliver. Our organization and processes are fluid, allowing us to act quickly on emerging business opportunities.
Lytics was featured in an article in a series of articles about the top 25 artificial intelligence solution providers 2017. The article named “Bringing Healthcare at your Finger Tips” talks about Lytics’ developed solution LYTICS VÖR®.
Principal investigator and consultant Niklas Nielsen, noted for his pioneering work in clinical trials regarding the effects of cooling published in New England Journal of Medicine, has signed an agreement with Lytics for yet another large international multicenter clinical trial. The trial, TTM2, has due to the immense success of the previous trial received much attention.
Lytics was featured in an article about AI-companies within healthcare in Swedish national technology magazine NyTeknik. The article features Lytics as one of two examples of AI-companies within healthcare and the business risks involved in the industry.
Lytics completes a 4.8 MSEK round of financing backed by private equity. The all-equity financing round included new investors. Also participating in the round were existing Lytics investors Swedish Growth Fund, which has been an investor in Lytics since the spring of 2015.
Principal investigator and consultant cardiologist Matthias Götberg, noted for his pioneering work in cardiology and national quality registries, and his associate, Associate Professor and thoracic surgeon Henrik Bjursten, noted for his research in valve replacement and CABG has signed an agreement with Lytics for an international multicenter clinical trial. Lytics SIF® technology within electronic data capture will facilitate the data capture of the trial. The trial is funded by Boston Scientific Corporation.
Principal investigator Professor Ole Fröbert, noted for his pioneering work in randomized registry clinical trials published in New England Journal of Medicine, has signed an agreement with Lytics for a large international multicenter clinical trial. The trial, IAMI, has a Swedish arm that is a randomized registry clinical trial.
Lytics gives a seminar at Foo Café, Media Evolution City in Malmö on Tuesday 24th of November between 17:30-20:00. On the topic Applied Artificial Intelligence Lytics CEO Mattias Paulsson will provide an introduction to Artificial Intelligence solutions aimed at the healthcare setting. During the interval pizza and beer will be served.
One of the parts of the rebranding is the name change and with it comes a new logo. "Lytics is shorter and more to the point and came naturally as we have used the name internally” says Mattias Paulsson, Partner & CEO of Lytics. Lytics is using the .ai domain to highlight the business area.
Mattias Paulsson, CEO & Partner of Lytics once again participates as a jury member in the KPMG International Case Competition in Lund, Sweden. The Swedish KICC in Lund is the national qualification for the international KICC in Dubai, UAE. Mattias has an affinity for case competitions and serving the student community having competed in the very first KPMG International Case Competition. Today it is one of the biggest case competitions in the world with more than 16,000 participants.